AA
ABBV icon

Argent Advisors’s AbbVie ABBV Stock Holding History

Argent Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$652K Sell
2,592
-34
-1% -$7.32K 0.16% 109
2026
Q1 		$571K Sell
2,626
-167
-6% -$37K 0.16% 116
2025
Q4 		$638K Sell
2,793
-12
-0.4% -$2.73K 0.18% 103
2025
Q3 		$649K Buy
2,805
+453
+19% +$92.2K 0.19% 97
2025
Q2 		$437K Buy
2,352
+70
+3% +$13K 0.13% 112
2025
Q1 		$478K Buy
2,282
+78
+4% +$15.2K 0.16% 107
2024
Q4 		$392K Sell
2,204
-127
-5% -$23.4K 0.15% 103
2024
Q3 		$460K Sell
2,331
-149
-6% -$27.8K 0.17% 104
2024
Q2 		$425K Sell
2,480
-344
-12% -$57K 0.17% 101
2024
Q1 		$514K Sell
2,824
-876
-24% -$151K 0.2% 93
2023
Q4 		$573K Sell
3,700
-143
-4% -$20.8K 0.25% 87
2023
Q3 		$573K Sell
3,843
-189
-5% -$27.7K 0.26% 84
2023
Q2 		$543K Sell
4,032
-351
-8% -$51.5K 0.25% 83
2023
Q1 		$699K Buy
4,383
+135
+3% +$20.6K 0.33% 71
2022
Q4 		$687K Buy
4,248
+65
+2% +$9.97K 0.36% 68
2022
Q3 		$561K Buy
4,183
+189
+5% +$27.1K 0.33% 72
2022
Q2 		$612K Sell
3,994
-453
-10% -$69.2K 0.34% 74
2022
Q1 		$721K Buy
4,447
+374
+9% +$54.3K 0.39% 73
2021
Q4 		$551K Buy
4,073
+2,017
+98% +$238K 0.3% 81
2021
Q3 		$222K Buy
2,056
+25
+1% +$2.86K 0.13% 126
2021
Q2 		$229K Buy
2,031
+35
+2% +$3.94K 0.14% 123
2021
Q1 		$216K Sell
1,996
-2,591
-56% -$277K 0.14% 126
2020
Q4 		$491K Buy
4,587
+350
+8% +$33.6K 0.3% 89
2020
Q3 		$371K Hold
4,237
– – 0.25% 97
2020
Q2 		$415K Buy
4,237
+1,426
+51% +$126K 0.32% 88
2020
Q1 		$214K Hold
2,811
– – 0.21% 108
2019
Q4 		$248K Buy
+2,811
New +$233K 0.19% 96

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Argent Advisors's ABBV Position: Q2 2026 in Review

Argent Advisors reduced its AbbVie (ABBV) stake by 1.3% in Q2 2026, selling an estimated $7.32K and leaving 2,592 shares worth $652K. The position accounts for 0.16% of the portfolio, ranked #109.

Argent Advisors first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $721K in Q1 2022. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Argent Advisors held 2,592 shares of AbbVie worth $652K as of Q2 2026.
  • Argent Advisors sold 34 AbbVie shares in Q2 2026, an estimated $7.32K.
  • AbbVie made up 0.16% of Argent Advisors's portfolio in Q2 2026, its #109 holding.
  • Argent Advisors first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • Argent Advisors's AbbVie position peaked at $721K in Q1 2022.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Argent Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.